Awardee: Taylor Clark, PharmD

Clinical Assistant Professor, Ambulatory Care

Department of Pharmacy Practice

School of Pharmacy and Pharmaceutical Sciences | Binghamton University

Project Title: Innovating Contraceptive Access: Pilot of a Pharmacist-Led Pop-Up Clinic

Bio/overview of project: Dr. Taylor Clark is a clinical pharmacist specializing in ambulatory care with a focus on women’s health and advancing pharmacist-provided clinical services. Her work centers on expanding access to evidence-based care and integrating pharmacists into preventive health roles. Her current project aims to implement pharmacist-run pop-up contraception clinics within outpatient pharmacies in the Southern Tier of New York, a region where these services are not currently available. The initiative will evaluate access, utilization, and patient experience, with a focus on reaching undeserved populations and improving continuity of contraceptive care. Findings from this work will help inform scalable models for pharmacist-prescribed contraception and support the expansion of clinical pharmacy practice across New York State.

Awardee: Kelly Bach, PharmD, BCPS, BCCCP, BCGP

Clinical Assistant Professor, Pharmacy Practice

Department of Pharmacy Practice

School of Pharmacy and Pharmaceutical Sciences | Binghamton University

Project Title: Impact of a Medication Management Program on Clinical Outcomes for Diabetes and Hypertension: Bridging the Barriers Associated with Social Determinants of Health in the Southern Tier

Bio/overview of project: Kelly Bach, PharmD, BCPS, BCCCP, BCGP and Keri Dwyer, PharmD are Clinical Assistant Professors in the Department of Pharmacy Practice at Binghamton University School of Pharmacy and Pharmaceutical Sciences. Both faculty members provide clinical pharmacy services to the family medicine resident teaching team at Guthrie Lourdes Hospital where they precept APPE students. Their research project that is supported by the NYS ACCP grant is evaluating clinical outcomes of patients with diabetes and/or hypertension who are enrolled in the medication management program at Guthrie Binghamton Pharmacy. Additionally, we plan to evaluate the impact of the program on hospitalization rates, inpatient days, and emergency department utilization. We would like to thank NYS ACCP for selecting our project for this grant.

Awardee: Renae Lowery, PharmD, BCCCP

Cardiac Intensive Care Unit Clinical Pharmacy Specialist

University of Rochester Medical Center-Strong Memorial Hospital

Project Title: High INR for HM3 LVAD: Reverse or Drift?

Bio/overview of project: Renae Lowery, CVICU Clinical Pharmacy Specialist at the University of Rochester Medical Center, is co-precepting with YeeAnn Chen, Advanced Heart Failure/Heart Transplant Clinical Pharmacy Specialist. Anecdotally, there has been an increase in bleeding complications among HM3 LVAD patients at our institution whose warfarin is not reversed at the time of a supratherapeutic INR in the absence of active bleeding. However, there is limited literature and guidance regarding the reversal threshold for supratherapeutic INR in LVAD patients without evidence of bleeding. This study, led by PGY1 pharmacy resident Olivia Ormsby and PGY2 critical care pharmacy resident Rachel Bishop, evaluated whether warfarin reversal is warranted in HM3 LVAD patients with an INR ≥ 5 in the absence of active bleeding. The primary endpoint was major bleeding within 1 week of initial INR ≥ 5, defined by Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) criteria Types 3-5. Secondary endpoints included thrombotic or non-major bleeding events within 1 week of initial INR ≥ 5, hospital and intensive care unit length of stay, and mortality.